Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity
Science Advances · 2026
DOI: 10.1126/sciadv.aea3703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Jesse Garcia Castillo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Homeostasis, Neoplasms, Calcium-Binding Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
A burgeoning approach to treating cancer is the pharmacological induction of ferroptotic cell death of tumor cells. However, the impact of disrupting antiferroptotic pathways in the broader tumor microenvironment (TME), such as in immune cells, is still undefined and may complicate treatments. Here, we show that ferroptosis suppressor protein 1 (FSP1 /Aifm2 ) is critically required for regulatory T cell (T reg cell) resistance to ferroptosis and their immunosuppressive function within the TME. Compared to other canonical ferroptosis regulators such as GPX4 and NRF2, only FSP1 was induced upon T cell activation. Deletion of Aifm2 in all T cells, or T reg cells specifically, enhanced tumor control by selectively disrupting T reg cell immunosuppression within tumors without inciting autoimmune pathology in mice. As opposed to deletion of Gpx4 in all T cells, T cell deletion of Aifm2 did not impair antigen-specific CD8 + T cell responses. These results reveal an opportunity for targeting a regulator of ferroptosis that can not only directly target cancer cells but also simultaneously enhance anticancer immune responses without inciting autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
- Division of Molecular Therapeutics, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
- Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.
ORCID-Profile: Jesse Garcia Castillo, Stephanie Silveria, Jessica Hung, Grace Jaworski, Hei Sook Sul, James A Olzmann, Michel DuPage
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- UC CRCC Cancer Research Coordinating Committee
Zitieren
APA
Castillo, J. G., Silveria, S., Schirokauer, L., Sauquet, A., Hung, J., Jaworski, G., Hendricks, J. M., Sul, H. S., Olzmann, J. A., & DuPage, M. (2026). Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity. Science Advances. https://doi.org/10.1126/sciadv.aea3703
Vancouver
Castillo JG, Silveria S, Schirokauer L, Sauquet A, Hung J, Jaworski G, et al. Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity. Science Advances. 2026. doi:10.1126/sciadv.aea3703
BibTeX
@article{Castillo2026,
author = {Castillo, Jesse Garcia and Silveria, Stephanie and Schirokauer, Leo and Sauquet, Antoine and Hung, Jessica and Jaworski, Grace and Hendricks, Joseph M and Sul, Hei Sook and Olzmann, James A and DuPage, Michel},
title = {Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aea3703}
}
EUVIMED